Proper cell communication within the ovarian follicle is critical for the growth and maturation of a healthy oocyte that can be fertilized and develop into an embryo. Cell communication within the follicle involves many signaling molecules and is affected by maternal age. Recent studies indicate that cell communication can be mediated through secretion and uptake of small membrane-enclosed vesicles. The goals of this study were to 1) identify cell-secreted vesicles (microvesicles and exosomes) containing miRNAs and proteins within ovarian follicular fluid and 2) determine if miRNA level differs in exosomes isolated from follicular fluid in young compared to old mares. We demonstrate the presence of vesicles resembling microvesicles and exosomes in ovarian follicular fluid using transmission electron microscopy and CD63-positive and RNA containing vesicles using flow cytometry. Moreover, proteomics analysis reveals that follicular fluid-isolated exosomes contain both known exosomal proteins and proteins not previously reported in isolated exosomes. MicroRNAs were detected in microvesicle and exosomes preparations isolated from follicular fluid by real-time PCR analysis. Uptake of fluorescent-labeled microvesicles by granulosa cells was examined using in vitro and in vivo approaches. MicroRNA expression profiling reveals that miRNAs in microvesicle and exosome preparations isolated from follicular fluid also are present within surrounding granulosa and cumulus cells. These studies revealed that cell communication within the mammalian ovarian follicle may involve transfer of bioactive material by microvesicles and exosomes. Finally, miRNAs present in exosomes from ovarian follicular fluid varied with the age of the mare, and a number of different miRNAs were detected in young vs. old mare follicular fluid.
INTRODUCTION
The process of ovarian follicular growth and maturation (folliculogenesis) involves extensive cell-to-cell communication between somatic cells (theca, granulosa, and cumulus cells) and somatic cells and oocytes (e.g., Eppig [1] and Matzuk et al. [2] ). Members of the TGFB and WNT signaling family are involved in regulating follicular growth and maturation and comprise many of the signaling molecules that are part of the cell communication process (reviewed in Knight et al. [3] and Boyer et al. [4] ). Oocyte competence is acquired during folliculogenesis, and ultimately the coordinated communication and signaling between the different follicular cell types is critical for the growth, maturation, and release of an oocyte that can be fertilized and develop into an embryo.
Follicular fluid has been recognized as a source of biochemical factors that can be predictive of oocyte quality. Follicular fluid provides an important microenvironment for oocyte maturation and contains hormones (e.g., FSH, LH, GH, inhibin, activin, estrogens, and androgens), antiapoptotic factors (e.g., TNF and Fas-ligand), proteins, peptides, amino acids, and nucleotides (reviewed in Revelli et al. [5] ). Thus, it is logical to think that products contained within follicular fluid play a role in follicle growth and oocyte maturation. Studies revealed that follicular fluid is a product of both blood plasma and the secretory activity of granulosa cells [6, 7] . However, it is unclear if or how surrounding follicular cells respond to these factors during follicle development.
Recent studies have demonstrated that membrane-enclosed vesicles called microvesicles are released by cells and contain bioactive molecules (i.e., proteins and RNAs [mRNAs and miRNAs; [8] [9] [10] [11] . Microvesicles have been identified in body fluids such as blood plasma, urine, ascites fluid, and saliva. Microvesicles are secreted by cells through unconventional exocytosis. These vesicles are heterogeneous in size (;100-1000 nm) and are released from cells by outward budding andfission of the plasma membrane [12] . Microvesicles are distinct from apoptotic blebs, which contain cytosolic organelles and/or nuclear fragments [13] . Similar to microvesicles, exosomes also are membrane-enclosed vesicles but are more homogeneous and smaller in size (50-100 nm) than microvesicles and are derived from late endosomal compartments (multivesicular bodies [MVBs] ) in cells [14, 15] . Endocytotic invagination leads to MVBs containing several exosomes that in turn are released into the extracellular space when MVBs fuse with the plasma membrane. Similar to microvesicles, exosomes contain bioactive material (including mRNAs and miRNAs), can be transported over large distances through blood, and are taken up by cells. It has been speculated that microvesicles and exosomes play an important role in cell communication by transferring proteins, RNA, and/or miRNA molecules to target cells [11, 16] . Currently, a role for these vesicles and/or miRNAs in follicle growth and oocyte maturation is unknown. MicroRNAs (;22 nucleotides) serve as important regulators of gene function in a variety of different tissues, are highly conserved between species, and in many cases exhibit tissuespecific expression patterns. MicroRNA regulation of target gene expression occurs by base-pairing interaction with the 3 0 untranslated region of mRNA targets leading to mRNA cleavage or translational repression [17, 18] . The presence of miRNAs (and possible endogenous siRNAs) is necessary for female fertility in mice (reviewed in Luense et al. [19] ). Moreover, miRNAs are present in blood plasma, and serum and can be used as diagnostic markers in prostate and ovarian cancers [20, 21] .
In this study, we explored the possibility that cell-secreted vesicles (microvesicles and exosomes) are present in equine ovarian follicular fluid and contain miRNAs and proteins. The mare is an excellent model to study human follicular growth and oocyte maturation [22] ; follicular waves and endocrine profiles are similar between women and mares, both are monovular, and there are similar age-related changes in the reproductive cycles. An additional benefit is the large size of the equine follicle, allowing follicular contents (i.e., follicular cells and fluid) to be sampled and collected with relative ease. Transmission electron microscopy (TEM), flow cytometry, and proteomics analysis revealed that cell-secreted vesicles (microvesicles and exosomes) are present in ovarian follicular fluid, and fluorescent microscopy demonstrated that microvesicles are taken up by surrounding granulosa cells. Expressionprofiling experiments identified miRNAs present in microvesicles, exosomes within ovarian follicular fluid likely originate from within the follicle, and a number of different miRNAs were present in exosomes isolated from ovarian follicular fluid from old compared to young mares.
MATERIALS AND METHODS
A series of experiments were conducted to investigate the presence and potential role of cell-secreted vesicles (microvesicles and exosomes) in ovarian follicular fluid. To this end, follicular fluid and cells were aspirated from dominant follicles (!35 mm) from young (3-13 yr) estrous mares and processed for TEM, flow cytometry, microvesicle/exosomes isolation, cell culture, and/or RNA and protein isolation. In addition, follicular fluid was aspirated from dominant follicles (!35 mm) from old (!20 yr) estrous mares and processed for exosomes and miRNA isolation.
Collection of Ovarian Follicular Cells and Fluid
Ovarian follicular fluid (10 ml) and cells (granulosa and cumulus cells) were obtained from light-horse, young and old mares. All procedures were done in accordance with the Colorado State University Institutional Animal Care and Use Committee. Mares were housed on dry lots with water and hay ad libitum. Follicular maturation was induced by administration of hCG and/or deslorelin (2500 IU and 1.5 mg, respectively, i.v.), and follicular contents (follicle !35 mm) were collected 32 h later by transvaginal, ultrasound-guided follicular aspirations [23] . Follicular fluid was collected using a 12-gauge needle, placed in an incubator at 378C for 10-20 min, centrifuged at 1500 3 g for 15 min, and later stored at À808C until processed for microvesicles/ exosomes, RNA, or protein isolation. Follicular cells (granulosa and cumulus cells) were rinsed (33) to remove red blood cells in PBS containing 0.02% polyvinyl alcohol (PVA); approximately half the sample was snap frozen and used for RNA isolation, whereas the rest was placed in medium (DMEM/F-12 [Invitrogen #11320-033] supplemented with 10% fetal bovine serum [FBS]) according to previously published methods [24, 25] . Cells were pipetted repeatedly to separate cells and placed in 23 freezing medium (50% FBS, 20% dimethyl sulfoxide, and 30% DMEM/F-12) in a freezing container overnight at À808C and stored until further use in microvesicle labeling and uptake experiments (see below).
Isolation of Microvesicles and Exosomes from Follicular Fluid
Cell-secreted vesicles were isolated from blood serum (used as a positive control) and ovarian follicular fluid through a series of differential ultracentrifugation steps as described in Thery et al. [26] . Samples were spun at 300 3 g for 10 min and 2000 3 g for 10 min to remove residual cells and debris, at 10 000 3 g for 30 min to remove microparticles, and two times at 100 000 3 g for 70 min (33 000 rpm, rotor SW55) to pellet the microvesicles. The pellets were resuspended in 500 ll of PBS (pH 7.4) and used for flow cytometry (n ¼ 2), real-time PCR analysis (n ¼ 3), or fluorescent labeling (n ¼ 3).
Exosomes were isolated using Exoquick (SBI System Biosciences, Inc.). Exoquick is a polymer-based reagent created to enrich preparations for exosomes. Blood serum (used as a positive control) and follicular fluid were centrifuged at 3000 rpm for 15 min after collection, and 400 ll of the supernatant were added to 100 ll of Exoquick. This preparation was incubated 12 h at 48C and centrifuged 1500 rpm for 30 min to obtain an exosome pellet. Exosome pellets were resuspended in 500 ll of PBS (pH 7.4) and used for flow cytometry (n ¼ 2), realtime PCR analysis (n ¼ 3), or proteomics analysis (n ¼ 3).
Flow Cytometry
Microvesicle and exosomes preparations isolated from follicular fluid of young mares were incubated with 1 lg/ll CD63-FITC conjugated antibody (AHN16.1/46-4-5; Santa Cruz Biotechnology, Inc.) and 5 ll/ml Acridine Orange (AO; BD-Diagnostic System). CD63 is a tretraspanin superfamily protein member present in exosomes, and AO is a cell-permeable stain that binds RNA. CD63-FITC antibody and AO were added for 30 min prior to flow cytometry.
Samples were filtered through a sterile mesh with pore size 122 lm to remove any clumps. Flow cytometry was conducted on a MoFlo Legacy Flow Cytometer by DAKO-Cytomation (Beckman-Coulter), using a laser at 488 nm and 100-mW power. Dyes used were AO (high voltage ¼ 608) and FITC (high voltage ¼ 527), and fluorescence was analyzed for forward scatter and side scatter measured using log histograms and log scale. Isolated microvesicle and exosome preparations from follicular fluid samples were compared to microvesicle and exosome preparations from blood samples that were used as controls.
Transmission Electron Microscopy
Isolated cell-secreted vesicle preparations (n ¼ 2 mares) were fixed in 2.5% glutaraldehyde, 5% sucrose, and 0.1 M sodium cacodylate at pH 7.4 for 30 min at room temperature. The pellet was postfixed in a solution of 1% osmium tetroxide in 0.1 M cacodylate buffer and centrifuged. Osmicated pellets were dehydrated through a graded series of ethanol, rinsed in propylene oxide, and embedded in Poly/Bed 812 (Polysciences Inc.). From these tissue blocks, ;80-nm-thin sections were cut, mounted on 300-mesh nickel grids, stained with uranyl acetate and lead citrate, and examined using a JEOL-JEM-1200EX transmission electron microscope.
Protein Isolation and Mass Spectrometry
Exosomes were isolated from follicular fluid collected from dominant follicles (32 h following hCG/deslorelin administration) of three young mares. Following an overnight precipitation, exosomal proteins were isolated using TRI reagent BD (Molecular Research) and resuspended in 8 M urea. Samples were depleted of albumin and IgG using the ProteoExtract Removal Kit (Calbiochem) and concentrated using Amicon Ultra centrifugal filters (Millipore Corp.). Protein samples (50 lg) underwent in-solution digestion using Protease Max (Promega) and urea. Briefly, samples were solubilized in 8 M urea, 0.2% protease max, and then reduced, alkylated, and digested with 1% protease max and trypsin at 378C for 3 h. Samples were dried in a Speed Vac vacuum centrifuge, desalted using Pierce PepClean C18 spin columns (Pierce), dried, and resuspended in 10 ll acetonitrile (ACN; 3%), formic acid (0.1%). Online two-dimensional liquid chromatography/mass spectrometry/mass spectrometry (LC-MS/MS) with SCX (strong cation exchange) and subsequent reverse-phase chromatography was performed as follows. Digested peptides (10 lg) from each sample were loaded onto a Zorbax BIO-SCX II 3.5 lm, 50 3 0.8-mm column (Agilent Technologies). Peptides were eluted off from the SCX column stepwise using increasing concentrations of NaCl in 0.3% ACN, 0.1% FA (NaCl salt injections: 15, 30, 45, 60, 75, 90, 120, 150, 300, and 500 mM). Peptides from each individual salt injection were then purified and concentrated using an online enrichment column (Agilent Zorbax C18, 5 lm, 5 3 0.3 mm). Subsequent chromatographic separation was performed on a reverse-phase nanospray column (Agilent 1100 nanoHPLC, Zorbax C18, 5 lm, 75 lm inner diameter 3 150 mm column) using a 60-min linear gradient from 25% to 55% buffer B (90% ACN, 0.1% formic acid) at a flow rate of 300 nl/min. Peptides were eluted directly into the mass spectrometer (Thermo Scientific LTQ linear ion trap), and spectra were collected over a m/z range of 200-2000 Da using a dynamic exclusion limit of 2 MS/MS spectra of a given peptide mass for 30 sec DA SILVEIRA ET AL.
(exclusion duration of 90 sec). Compound lists of the resulting spectra were generated using Bioworks 3.0 software (Thermo Scientific) with an intensity threshold set at 5000 and one scan per group. This workflow generates 10 raw data files per sample. MS/MS spectra were searched against the appropriate protein database (NCBI 2008, equine taxonomy filter, 68 020 entries) using the Mascot database search engine (version 2.3). The 10 data files per sample were then combined using the ''mudpit'' option in Scaffold 3 (Proteome Software), generating a composite listing of all proteins identified from the 10 runs for each sample. Data files from the biological replicates were combined in Scaffold 3, generating one list of identified proteins. Thresholds were set to 99.9% protein probability, two-peptide minimum, and a custom peptide threshold was used that combines Scaffold 3 algorithms and the Mascot score. Peptide false discovery rate (FDR) was less than 0.5%. All solvents, water, and acid used were LC-MS/MS grade from Sigma.
Western Blot Analysis
Exosomal proteins (with and without albumin and IgG depletion) were isolated using TRI reagent BD (Molecular Research) and resuspended in 8 M urea. Protein concentration was determined using the Bradford assay, and 50 lg were loaded and resolved in 10% SDS-PAGE polyacrylamide gels (Bio-Rad Corp.). Protein samples were run at 30 mA for 30 min and transferred to nitrocellulose membranes (Biotrace NT, Pall life Sciences) for 1 h at 100 V. Membranes were incubated in blocking buffer (5% nonfat dried milk in TBST) for 1 h at room temperature, and presence of inhibin alpha (INHA) was assessed by exposing the membranes to a monoclonal antibody (2 lg/ml, sc-22048, Santa Cruz Biotechnology Inc.) overnight at 48C. In addition, membranes were incubated with antibodies raised against HSP70 (HSPA; 1:5000, ab79852; Abcam) and CYT C (0.4 lg/ml, sc13156; Santa Cruz Biotechnology). Membranes were washed three times in 13 TBST for 5 min and incubated for 1 h at room temperature with a horseradish peroxidase conjugated anti-goat secondary antibody (0.4 lg/ml, sc-2020; Santa Cruz Biotechnology), horseradish peroxidase conjugated anti-rabbit secondary antibody (0.2 lg/ml, sc-2004; Santa Cruz Biotechnology), or horseradish peroxidase conjugated anti-mouse secondary antibody (0.4 lg/ml, sc-13156; Santa Cruz Biotechnology), respectively. Membranes were washed three times in 13 TBST for 5 min and incubated for 5 min in ECL Plus Western Blotting Detection System solution (Amersham) for color development.
Vesicle Labeling
Cell-secreted vesicles obtained by differential ultracentrifugation (microvesicles and exosomes) were collected from follicular fluid of the dominant follicles of three young mares and were labeled with PKH67 (Molecular Probes and Invitrogen), a green fluorescent dye that labels the lipid membranes. This preparation containing primarily microvesicles (see results below) was incubated in 2 ll PKH67 (2 lM) for 5 min, followed by incubation in 1% BSA for 1 min at room temperature, washed four times with FBS-free medium (DMEM F-12) to remove excess dye, and resuspended in DMEM F-12 medium according manufacturer's instructions. For a negative control, sterile PBS was incubated with PKH67 and treated the same as described above. The labeled microvesicles or PBS (negative control) was used to determine their uptake by granulosa cell in vitro and in vivo (described below).
Microvesicle Uptake by Granulosa Cell Culture
Granulosa cells from the dominant follicles of three young mares were thawed at 378C for 5 min and placed in 1:1 freezing medium to DMEM/F-12 overnight in 60-mm dishes. Medium was replaced after the first day to remove any dead cells and then replaced every 2 days. To study microvesicle uptake, granulosa cells were collected using 500 ll trypsin, transferred to chamber slides (Bab-Tek Chamber Slide System 154534 NUNC; ;45 000 cells per chamber), and cultured overnight in 200 ll DMEM/F-12 medium. Microvesicle uptake was determined after granulosa cells had attached to the slides, and replacing medium with DMEM/F-12 without FBS, supplemented with labeled microvesicles (3.6 lg/ll protein; diluted in 50 ll DMEM/F-12 media). After 22 h, cells were fixed with 70% ethanol, and presence of fluorescent-labeled microvesicles in granulosa cells was ascertained using a Nikon Eclipse E800 fluorescence microscope. These experiments were performed three times, each time using labeled microvesicles isolated from follicular fluid of a different young mare and labeled PBS as negative control.
Microvesicle Uptake In Vivo
Four hours after collection of follicular fluid of estrous mares, fluorescentlabeled microvesicles (obtained by differential ultracentrifugation) were injected back into the antrum of the same follicle from which it originated. Deslorelin (1.1 mg, i.m.) was administered to mares, and follicular cells were aspirated 22-24 h later. Granulosa cells were fixed in 70% ethanol for 10 min and stained with 4 0 ,6-diamidino-2-phenylindole (DAPI). Presence of fluorescent-labeled microvesicles within granulosa cells was evaluated using LSM 510 Meta 405 Confocal Microscope System Zeiss or Olympus FSX100. A series of images were collected at 0.05-lm intervals and used to generate a z-stack. This experiment was performed each time using labeled microvesicles isolated from follicular fluid from three independent young mares and labeled PBS as negative control in an additional three mares.
MicroRNA Isolation and Reverse Transcription
Total RNA and miRNA were isolated from follicular fluid, microvesicle, and exosome preparations isolated from follicular fluid and granulosa and cumulus cells using TRI-REAGENT BD (Molecular Research) according to the manufacturer's instructions. RNA concentration and purity were determined using the NanoDrop ND-1000 spectrophotometer. Samples were stored at À808C.
Quantifiable cDNA was generated using the QuantiMir RT Kit (Systems Biosciences [SBI], Mountain View, CA) according to the manufacturer's instructions. Briefly, approximately 500 ng of total RNA, including the small RNA fraction, were anchor tailed with polyA by incubating RNA, 53 PolyA Buffer, 25 mM MnCl 2 , 5 mM ATP, and polyA polymerase at 378C for 30 min. Oligo (dT) adapters were annealed at 608C for 5 min, and reverse transcription was carried out by incubating the samples at 428C for 60 min followed by 958C for 10 min.
Real-Time PCR Expression Analysis of miRNAs
The expression of mature miRNAs was examined in microvesicle and exosome preparations isolated from three different animals in each group (i.e., young and old mares) using Human miRNome Profiler plates (SBI). In addition, expression of mature miRNAs also was examined in granulosa and cumulus cells from young mares (n ¼ 3). The human miRNome Profiler plate contains 381 mature miRNA sequences (used as forward primers) and three endogenous controls: U6 snRNA, RNU43 snoRNA, and U1 snRNA. Comparing these mature miRNA sequences to recently available equine mature miRNA sequences (http://www.mirbase.org), 221 are identical in sequence, 11 miRNAs were different in size (5 0 or 3 0 nucleotides added or removed), and 27 miRNA sequences contained nucleotide differences (18 miRNAs with only a single nucleotide difference). For 122 miRNAs, no equine sequence was available (Supplemental Table S1 ; all Supplemental Data are available online at www.biolreprod.org). Each analysis was performed in 6-ll reactions containing 23 SYBR Green I master mix (Roche Applied Sciences), 10 lM Universal reverse primer and miRNA specific forward primer (SBI), and 0.1 ll cDNA. Real-time PCR was conducted using the LightCycler480 PCR system (Roche Applied Sciences) with 384-well plates. The PCR cycle conditions were as follows: 958C for 5 min, 45 cycles of 958C for 10 sec, 608C for 15 sec, and 728C for 15 sec followed by a melt curve analysis to confirm amplification of single cDNA products. To identify differences in the presence of exosomal miRNAs isolated from follicular fluid of young and old mares, raw Cp values were normalized to U1 snRNA, and statistical differences were assessed at P 0.05 using a Student t-test.
RESULTS

Presence of Microvesicles and Exosomes in Equine Follicular Fluid
Differential ultracentrifugation and Exoquick precipitation of equine follicular fluid followed by TEM revealed that different-sized vesicles resembling microvesicles and exosomes were present in ovarian follicular fluid (Fig. 1, A and B) . Differential ultracentrifugation yielded a preparation containing primarily microvesicles and few exosomes (herein referred to as microvesicle preparation), whereas Exoquick precipitation yielded a highly enriched preparation of exosomes. Furthermore, flow cytometric analysis demonstrated that these isolated preparations both contained vesicles positive for CD63 and RNA (Fig. 1, C and D) .
Proteomics analysis revealed 73 proteins in exosomes isolated from follicular fluid, with 44 proteins previously identified in exosomes isolated from a variety of fluids, CELL-SECRETED VESICLES IN OVARIAN FOLLICULAR FLUID including serum, plasma, urine, and saliva (ExoCarta [27] ). In addition, peptide sequences were detected corresponding to 29 proteins not previously reported in exosomes, including INHA chain precursor (Table 1 ). Western blot analysis using an antibody designed against the C-terminal region of INHA, revealed an ;18-kDa band (mature INHA) in addition to the predicted ;37 kDa for INHA precursor (Fig. 2) . Furthermore, the exosomes protein preparations were positive for HSP70 (positive control) and negative for CYT C (negative control).
Presence of miRNAs in Microvesicles and Exosomes Isolated from Follicular Fluid and Surrounding Granulosa and Cumulus Cells
The presence of miRNAs in cell-secreted vesicles was examined by real-time PCR. MicroRNAs were considered to be present when the Cp value (number of cycles it takes to detect a fluorescence signal above background) was 37. Real-time PCR analysis revealed that microvesicles and exosomes isolated from follicular fluid contain miRNAs (n ¼ 3; Supplemental Tables S2 and S3) ; specifically, 79 miRNAs and 41 miRNAs were detected in microvesicles and exosomes, respectively ( Fig. 3; Table 2 ). Twenty-five miRNAs were present in microvesicles and exosomes isolated from follicular fluid. These 25 miRNAs are predicted to target several signaling pathways (DIANA-mirPath; http://diana.cslab.ece. ntua.gr), with the WNT signaling pathway the most significantly targeted pathway (Supplemental Table S4 ).
In addition to the miRNAs present in both microvesicles and exosomes, 54 miRNAs were enriched in the microvesicle preparation and 16 miRNAs in the exosome preparation ( Fig.  3 ; Table 2 ). In silico target prediction (DIANA-mirPath; http:// diana.cslab.ece.ntua.gr) revealed that the 54 microvesicular miRNAs target pathways including TGFB and MAPK signaling, whereas the 16 exosomal miRNAs target pathways including focal adhesion and regulation of actin cytoskeleton (Supplemental Table S5 and S6).
Presence of miRNAs also was examined in granulosa and cumulus cells. Table 3 illustrates that of the 381 miRNAs examined, 22 were detected (n ¼ 3; Cp value 37; standard deviation #1.0) only in granulosa cells and 35 only in cumulus cells. In addition, 17 miRNAs were detected in both granulosa and cumulus cells. Comparing the miRNAs that were detected in the microvesicle and exosomes preparation in follicular fluid to the ones present in follicular cells, 21 miRNAs in granulosa cells and 12 miRNAs in cumulus cells also were present in microvesicles and/or exosomes (Table 3 ). In general, miRNAs that were consistently detected in microvesicles or exosomes also were consistently present in granulosa cells or cumulus cells (see Tables 2 and 3) . DA SILVEIRA ET AL.
Microvesicle Uptake by Granulosa Cells In Vitro and In Vivo
Granulosa cells were cultured with green fluorescent-labeled (PKH67) microvesicles added to the culture media. Following a 24-h incubation, PKH67-labeled microvesicles were evident in cultured granulosa cells (Fig. 4) . Importantly, granulosa cells cultured in media with PKH67-treated sterile PBS were negative for green fluorescence.
Because granulosa cells took up fluorescent-labeled microvesicles in vitro, we explored the possibility this also occurred in vivo. Microvesicles were isolated, labeled with PKH67, and injected back into follicular fluid of the same dominant follicle from which it originated. Green fluorescent-labeled microvesicles were evident within the granulosa cells when follicles were injected with PKH67-labeled microvesicles (Fig. 5) , whereas no staining was observed when follicles were injected with PBS-incubated PKH67. Importantly, z-stack images obtained by confocal microscopy clearly revealed that the fluorescent-labeled vesicles were inside the granulosa cells (Fig. 5C ).
Exosomal miRNAs in Follicular Fluid Collected from Young and Old Mares
Real-time PCR analysis revealed a total of 22 and 13 miRNAs were present (Cp value 37; standard deviation 1.0) in exosomes isolated from young and old mares, a The exosomes database ExoCarta (http://exocarta.ludwig.edu.au) was used to determine whether exosomal proteins from ovarian follicular fluid have been identified in exosomes from other fluids.
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respectively (Table 4) . Moreover, 14 miRNAs were detected only in exosomes isolated from follicular fluid of young mares, and five miRNAs were detected only in exosomes from old mares. Finally, using normalized expression values, three miRNAs (MIR181A, MIR375, and MIR513A-3P) were expressed in significantly (P 0.05) higher amounts in exosomes isolated from follicular fluid of old compared to young mares ( Table 4) .
The most significantly targeted pathways by the exosomal miRNAs present only in follicular fluid from either young or old mares are MAPK signaling and focal adhesion (Supplemental Tables S7 and S8 ). The three miRNAs present at significantly higher amounts in exosomes collected from old compared to young mares were predicted to target TGFB signaling as the most significant pathway (Supplemental Table  S9 ).
DISCUSSION
Cells secrete microvesicles and exosomes that can travel over long distances when released into the bloodstream and potentially modulate cell function at remote target sites. Recent interest in microvesicles and exosomes comes from the observation that tumor cells secrete microvesicles/exosomes that have potential roles in cancer progression [28] [29] [30] . Microvesicles and exosomes are present in a variety of body fluids in health and disease (urine, blood, and ascites fluid), suggesting that they have a role in normal homeostasis and also are released under disease conditions. To our knowledge, this is the first report demonstrating that microvesicles and exosomes are present in ovarian follicular fluid.
Differential ultracentrifugation and Exoquick precipitation were used to isolate cell-secreted vesicles from ovarian follicular fluid. TEM, considered the ''gold standard'' in the identification/visualization of cell-secreted membrane vesicles (reviewed in Gyorgy et al. [31] ), revealed that differential ultracentrifugation of ovarian follicular fluid collected from young mares contained a variety of different-sized vesicles (Fig. 1A ) that corresponded to both the size and the shape reported for exosomes (50-100 nm) and microvesicles (100- DA SILVEIRA ET AL. 1000 nm; irregular shaped) isolated from serum [32, 33] , with most vesicles present in this preparation larger than 100 nm. Furthermore, TEM indicated that Exoquick precipitation of ovarian follicular fluid yielded a highly enriched fraction containing exosomes (Fig. 1B) . Using flow cytometry, CD63-positive vesicles were identified in follicular fluids that also were positive for AO, a dye that binds RNA. CD63 is enriched in exosomes [11, 27] , indicating that microvesicles and exosomes carrying RNA are present within ovarian follicular fluid, similar to what has been reported for blood. 
þþ Detected only in GC, CC and EXO miR-425 þþ miR-152 þþ þþ þ miR-502-5p þþ miR-512-3p þþ Detected only in GC, MV and EXO miR-532-3p
The presence of miRNAs in GC and CC was compared to their presence in microvesicle (MV) and exosome (EXO) preparations isolated from follicular fluid: þ ¼ Cp ! 30; þþ ¼ 25 Cp , 30; þþþ ¼ Cp , 25.
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Proteomic profiling studies [10, 34] revealed that exosomes contain a common set of membrane and cytosolic proteins in addition to cell-type-specific proteins. Using online twodimensional LC-MS/MS, peptide sequences resembling 73 proteins were identified in exosomes isolated from follicular fluid from young mares. Of these, 44 proteins are known to be exosomal proteins and have been identified previously in exosomes isolated from urine, plasma, serum, saliva, or culture media from different cell types (ExoCarta [27] ). Moreover, Western blot analysis validated the isolation of exosomal proteins and revealed these exosomal protein preparations were positive for HSPA (a known exosomal protein; ExoCarta) and negative for CYT C (present in cytosol/mitochondria and not in exosomes; ExoCarta). Twenty-nine exosomal proteins are identified that appear specific to exosomes within ovarian follicular fluid (i.e., they have not been identified previously according to ExoCarta, a large compendium of exosomal proteins). INHA and inhibin beta A chain precursors are two proteins present in the exosomes preparation obtained from ovarian follicular fluid, according to the proteomic screen. Western blot analysis using a specific antibody for INHA revealed an ;18-kDa band in addition to the predicted ;37-kDa band. The antibody does not distinguish between the mature or precursor form of INHA, and the ;18-kDa band corresponds to the size predicted for the mature form of INHA. The fainter ;18-kDa bands in the exosomal protein sample preparations following albumin and IgG depletion, indicates that the mature form of INHA maybe attached (directly or indirectly through albumin) to the exosomes. Inhibins have been detected in follicular fluid of cattle and horses ([35; reviewed in Beg et al. [36] ), and although its role in the process of dominant follicle selection still is unclear, inhibin A secretion by granulosa cells has been used as a indicator for the presence of a dominant follicle and corpus luteum function (reviewed in Knight and Glister [3] and Knight et al. [37] ). Moreover, inhibin levels reflect granulosa cell function and are used as diagnostic markers in female reproductive disease [38] . The identification of INHA (precursor) protein in exosome preparations within follicular fluid supports the idea that intrafollicular (paracrine) signaling by inhibins involves exosomal transport of INHA, something worth investigating.
Previous studies revealed that RNA, including miRNAs, present in blood also are present in microvesicles and exosomes. In this study, we used a human miRNome PCR profiling assay to demonstrate that miRNAs also are detected in follicular fluid (without isolating vesicles) and microvesicles and exosomes present in follicular fluid. When these experiments were initiated, no equine miRNA sequences were available. However, many mature miRNA sequences are conserved across species, and we previously used the miRNome PCR profiling approach to identify the presence of miRNAs in a domestic animal species [39] . Recently, equine miRNA sequences were deposited in the miRBase database (http://www.mirbase.org), revealing that, of the mature miRNAs that are common between human and horse, .80% were identical in sequence, and only 3% were different by more than one nucleotide in sequence. Using this PCR profiling assay, 25 DA SILVEIRA ET AL. miRNAs were identified that were present in both microvesicular and exosomal preparations. Interestingly, the most significant pathway targeted by these 25 miRNAs is the WNT signaling pathway (88 genes in this pathway are targeted). WNT molecules are glycoproteins involved in fetal ovarian development and adult ovarian function, including follicle growth, luteogenesis, and steroidogenesis [40] , whereas 54 miRNAs were enriched in microvesicles and 16 miRNAs enriched in exosomes. Microvesicles and exosomes are proposed to play a role in cell communication by delivering RNAs (miRNAs) and proteins from one cell to another and modulating cell function [9] . Although cell-cell communication is implicated in the development of the follicle and ovum, the precise mechanisms are yet to be delineated. Of particular interest is the observation that the predicted pathways targeted by miRNAs in microvesicles and exosomes include TGFB, WNT, and MAPK signaling pathways, pathways well known to be involved in regulating folliculogenesis.
To further investigate the possibility that microvesicular and exosomal miRNAs within follicular fluid play a role in ovarian follicle growth and development, we determined if granulosa cells take up these cell-secreted vesicles. In the first experiment, microvesicles were isolated from follicular fluid, fluorescently labeled, and added to cultured equine primary granulosa cells in vitro. Importantly, primary granulosa cells were cultured in a medium without FBS because endogenous microvesicles possibly are present in FBS. Fluorescent microscopy revealed the presence of green fluorescent vesicles in cultured primary granulosa cells. Moreover, in a second experiment, follicular fluid was collected, and microvesicles were isolated, fluorescently labeled, and injected back into the antrum of the same dominant follicle in vivo. The following day, follicular (granulosa) cells were aspirated, and the presence of green fluorescent vesicles again was evident within granulosa cells. Examining z-stack images taken at 0.05-lm intervals, it is evident that these labeled vesicles are present within the cells and not adhered to the outside extracellular matrix. These data indicate that microvesicles (and likely exosomes) present within follicular fluid can be taken up by surrounding follicular cells. However, it is unclear where the microvesicles are originating from, although it is likely that surrounding follicular cells (granulosa and cumulus cells) are cellular sources of microvesicles. Currently, these possibilities are being investigated in our laboratory.
To support the idea that microvesicles and exosomes in follicular fluid originate from within the ovarian follicle, we compared the miRNAs that are present within these vesicles to miRNAs detected in granulosa and cumulus cells. The miRNA PCR profile analysis indicates that both granulosa and cumulus cells contain distinct and overlapping sets of miRNAs. Importantly, miRNAs detected in microvesicles or exosomes isolated from follicular fluid also were detected in either granulosa cells or cumulus cells. A small number of miRNAs (11 in microvesicles and 7 in exosomes) did not appear to be present in granulosa or cumulus cells (compare Tables 1 and  3 ). However, this was due to our stringent criteria of defining miRNAs that are present in both vesicles and cells (Cp 37 and a standard deviation of 1.0). These miRNAs were present (Cp 37) in granulosa and/or cumulus cells; however, their level was more variable (standard deviation of !1.0) between the samples (n ¼ 3). Therefore, the observation that cell-secreted vesicles in follicular fluid and surrounding granulosa and cumulus cells contain a common set of miRNA leads us to conclude that microvesicles and exosomes likely originate from within the ovarian follicle. Future studies will validate these observations and focus on a functional role of these vesicular miRNAs.
The old mare has been used and is an excellent model to study age-related decline in ovarian function, specifically as relates to oocyte quality and competence (reviewed in Carnevale [22] ). In general, old mares (20 yr and older) have reduced fertility and compromised oocyte quality or developmental competence. To explore the possibility that exosomal miRNAs play a role in follicle growth and development, we examined the relative miRNA level in exosomes isolated from follicular fluid collected of young and old mares. Real-time PCR analysis revealed that 14 miRNAs in exosomes were consistently present in follicular fluid from young mares and five miRNAs in exosomes in follicular fluid from old mares. Bioinformatic analysis (DIANA-mirPath; http://diana.cslab. ece.ntua.gr) revealed that both sets of miRNAs present only in exosomes of follicular fluid from young and old mares target MAPK signaling and focal adhesion as the most significant pathways; however, more genes in each pathway (104 and 85 compared to 47 and 37, respectively) were targeted by miRNAs in exosomes isolated from follicular fluid of young mares. It is unclear whether exosomes containing these miRNAs are released in follicular fluid by follicular cells to initiate these signaling pathways and/or as a way to signal to other follicular cells to suppress or fine-tune MAPK signaling and focal adhesion signaling pathways.
Relative levels of MIR181A, MIR375, and MIR513a-3P in exosomes were significantly higher (P 0.05) in follicular fluid from old compared to young mares. The top pathway predicted to be targeted by these three miRNAs is TGFB signaling; 24 genes are potential targets in this pathway. The fact that the TGFB signaling pathways is critical for proper follicle development and growth [3] suggests that in old mares exosomes containing these miRNAs could suppress this pathway, leading to perturbed oocyte maturation. The identification of exosomal miRNAs expressed only or at relative 
higher expression in follicular fluid from old mares may lead to the development of novel biomarkers predictive of the agerelated decline in oocyte quality and competence. In summary, TEM and flow cytometry reveal the presence of microvesicles and exosomes within ovarian follicular fluid. Proteomics and real-time PCR expression analysis indicate that proteins and miRNAs are present within microvesicles and exosomes isolated from follicular fluid. Moreover, the same miRNAs also are present in surrounding follicular cells. Importantly, using both in vitro and in vivo approaches, we demonstrate that microvesicles isolated from ovarian follicular fluid could be taken up by surrounding granulosa cells. Based on these data, we propose that microvesicles and exosomes play a not previously recognized role in mediating cell communication within the mammalian ovarian follicle. Finally, using the mare as a model of age-related decline in oocyte quality, several exosomal miRNAs were identified that possibly correlate with age-related decline in oocyte quality.
